CPC A61K 9/2833 (2013.01) [A61K 9/204 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2072 (2013.01); A61K 9/284 (2013.01); A61K 31/4412 (2013.01); A61K 31/4422 (2013.01); A61P 7/06 (2018.01); A61P 25/28 (2018.01); A61P 35/00 (2018.01)] | 27 Claims |
1. A method for treating transfusional iron overload in a patient with thalassemia syndromes, comprising orally administering to the patient a tablet comprising:
(a) a core comprising (i) about 1000 mg deferiprone, (ii) an enteric polymer in an amount of about 1% to about 5% by weight of the core, (iii) a pH adjusting agent, and (iv) a glidant, and
(b) an enteric coating comprising (i) a plasticizer, (ii) an anti-tacking agent, (iii) an opacifying agent, and (iv) an enteric polymer.
|